SLC6A3 and Cognitive impairment: Considering the consistent associations between striatal DAT and cognition in various clinical groups (Chung et al., 2018; Cropley et al., 2006; Yang et al., 2022a), cognitive impairment could be a defining characteristic in patients with altered DAT levels.